Merck KGaA, Darmstadt, Germany, a leading science and technology company, today announced a significant leadership transition with the appointment of Jean-Charles Wirth and Danny Bar-Zohar to its Executive Board. Jean-Charles Wirth will assume the role of CEO, Life Science, while Danny Bar-Zohar becomes CEO, Healthcare.

This evolution in leadership signals the start of an exciting new chapter for the company. Both Jean-Charles and Danny bring decades of experience, deep company knowledge, and a shared vision for shaping the future of science and healthcare. Their leadership will be instrumental in advancing Merck KGaA’s strategy of sustainable innovation and global impact across its core sectors.

These appointments follow the recent addition of Khadija Ben Hammada as Chief People Officer, reflecting the company’s ongoing focus on building a strong, diverse, and future-ready Executive Board.

The company also expressed heartfelt appreciation to Dr. Matthias Heinzel and Peter Guenter, who are stepping down from their roles after years of exceptional service. Their leadership, strategic foresight, and dedication have laid the groundwork for continued success.